These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3552509)

  • 21. Metformin.
    Bailey CJ; Turner RC
    N Engl J Med; 1996 Feb; 334(9):574-9. PubMed ID: 8569826
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ; Ferner RE; Bailey CJ
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current role of metformin in treatment of diabetes mellitus type 2].
    Janssen JA
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1900-2. PubMed ID: 11045135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin and other antidiabetic agents in renal failure patients.
    Lalau JD; Arnouts P; Sharif A; De Broe ME
    Kidney Int; 2015 Feb; 87(2):308-22. PubMed ID: 24599253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biguanides. A review of history, pharmacodynamics and therapy.
    Schäfer G
    Diabete Metab; 1983; 9(2):148-63. PubMed ID: 6352352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of metformin on various aspects of glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus with varying degrees of hyperglycemia.
    Reaven GM
    Diabetes Metab Rev; 1995 Sep; 11 Suppl 1():S97-108. PubMed ID: 8529491
    [No Abstract]   [Full Text] [Related]  

  • 28. [Should the occurrence of a first coronary event change the management of diabetes?].
    Timsit J; Dubois-Laforgue D
    Arch Mal Coeur Vaiss; 2000 Dec; 93 Spec No 4():39-44. PubMed ID: 11296461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
    Fisman EZ; Motro M; Tenenbaum A
    Adv Cardiol; 2008; 45():154-170. PubMed ID: 18230961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is metformin safe enough for ageing type 2 diabetic patients?
    Gregorio F; Ambrosi F; Filipponi P; Manfrini S; Testa I
    Diabetes Metab; 1996 Feb; 22(1):43-50. PubMed ID: 8697295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin: preventable lactic acidosis.
    Prescrire Int; 2007 Feb; 16(87):19. PubMed ID: 17323526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined metformin-associated lactic acidosis and euglycemic ketoacidosis.
    Schwetz V; Eisner F; Schilcher G; Eller K; Plank J; Lind A; Pieber TR; Mader JK; Eller P
    Wien Klin Wochenschr; 2017 Sep; 129(17-18):646-649. PubMed ID: 28865058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Still sour about lactic acidosis years later: role of metformin in heart failure.
    Kuan W; Beavers CJ; Guglin ME
    Heart Fail Rev; 2018 May; 23(3):347-353. PubMed ID: 28868582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metformin-associated lactic acidosis].
    Orban JC; Ghaddab A; Chatti O; Ichai C
    Ann Fr Anesth Reanim; 2006 Oct; 25(10):1046-52. PubMed ID: 17005358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin induced lactic acidosis--particularities and course.
    Strugaru AM; Botnariu G; Agoroaei L; Grigoriu IC; Butnaru E
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):1035-42. PubMed ID: 24502087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
    Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pitfalls and precautions concerning the use of conventional oral antidiabetic drugs].
    Scheen AJ
    Rev Med Liege; 2002 May; 57(5):352-6. PubMed ID: 12143186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral antidiabetic combination therapy with sulphonylureas and metformin.
    Haupt E; Knick B; Koschinsky T; Liebermeister H; Schneider J; Hirche H
    Diabete Metab; 1991 May; 17(1 Pt 2):224-31. PubMed ID: 1936481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin: a new oral biguanide.
    Campbell RK; White JR; Saulie BA
    Clin Ther; 1996; 18(3):360-71; discussion 359. PubMed ID: 8829014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?
    Groop L; Widén E
    Diabete Metab; 1991 May; 17(1 Pt 2):218-23. PubMed ID: 1936480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.